[ad_1]
The University Hospital Basel (USB) and the private company Claraspital based in Basel want to establish a common center for the treatment of abdominal patients. In doing so, they want to make sure that in the long term, highly specialized drugs will be offered in the Basel region.
The "Clarunis" center combines the skills of both hospitals in visceral surgery and gastroenterology. Wednesday in front of the media. They expect more than 9,000 cases per year, of which about 350 are in highly specialized medicine. Sales are expected to reach CHF 25 million a year
The strategic partnership will address future challenges and health dynamics, said Claraspital President Raymond Cron. According to the chairman of the USB board Robert-Jan Bumbacher, major changes are needed to stay "comfortable" in the medium and long term.
Majority of votes and votes at Claraspital
a simple company in which Claraspital holds 55% and the USB 45% because of the number of cases involved. Approximately 150 employees from the two partner hospitals – the corresponding physicians, the specialized nurses and the case management – will have to move to "Clarunis". Outside looking for a manager.
A reduction in staff is not provided, said USB director Werner Kübler. The merger is "no saving exercise". Nevertheless, the partners hope that the expected increase in quality will also reduce costs, as stated agency director Peter Eichenberger. Claraspital also hopes to improve access to research. This will be reinforced with the center.
Current locations of partner hospitals should be preserved and continue to provide basic services and emergency services. In the future, however, highly specialized medicine will be used wherever the skill is greatest. Further cooperation in the region was also recommended by a commission from the University of Basel.
Separate Colonizations
With the new company, patients from the Basel area will continue to benefit from comprehensive support medical offers are available. Without merger threat according to long-term managers a loss of performance mandates in some highly specialized areas, because the required case numbers would not be achieved.
Existing cooperation and performance contracts of partner hospitals should be continued. In addition, the two hospitals continue to enter into their own contracts with insurers. They also charge for the services that they provide separately.
"Clarunis" could exist with or without the planned merger of Basel-Stadt and Basel-Land public hospitals at the North West University Hospital by 2020, officials said. If the parliament and the people of the hospital group of the two Basle are in agreement, the conditions of capital would change to "Clarunis". However, the majority of votes would remain at Claraspital
Governments Welcome Projects
The project has no influence on cooperation intentions in visceral surgery between USB and the Baselland Cantonal Hospital (KSBL) presented in early 2017. This would come into effect at the beginning of 2020. According to Bumbacher, the fact that the KSBL is not yet on board is due to the complexity of the project.
The launch of "Clarunis" is scheduled for January 1, 2019. The approval of the Competition Commission and tax issues remains open.
The plans are well received by the two Basel governments. This will strengthen university medicine in the Basel region, according to a joint statement. The alliance of a public and private non-profit institution has "a pioneering character throughout Switzerland". The Basel government received Tuesday the USB for outsourcing. (kha / sda)
created: 04.07.2018, 14:27
Source link
